
- With Mayo Clinic clinical neuropsychologist
Glenn Smith, Ph.D.
read biographyclose windowBiography of
Glenn Smith, Ph.D.
Glenn Smith, Ph.D.
Dr. Glenn Smith is a board-certified clinical neuropsychologist who specializes in Alzheimer's disease.
Dr. Smith, a Lincoln, Neb., native, has been with Mayo Clinic since 1990 and works with neurologists, psychiatrists, internists, social workers and nurses involved in diagnosing and providing care for people with dementia and their families.
"For Alzheimer's disease, there is currently no cure," he says. "The best 'medicine' for patient and family remains education and support. Hopefully, Mayo Clinic's Alzheimer's disease Web resources contribute to compassionate care and understanding for Alzheimer's families."
Dr. Smith is a professor of psychology at Mayo Clinic College of Medicine, a consultant in the Department of Psychiatry and Psychology, and principal investigator of the Mayo Alzheimer's Disease Research Center Education Core. He is past president of the American Board of Clinical Neuropsychology.
Risk factors (2)
- Alzheimer's: Can a head injury increase my risk?
- Oophorectomy (ovary removal): A risk factor for dementia?
Symptoms (1)
- Sundowning: Late-day confusion
Tests and diagnosis (2)
- Rapid-onset Alzheimer's: Could it be something else?
- Alzheimer's test: Detection at the earliest stages
Complications (1)
- Phantosmia: What causes olfactory hallucinations?
Treatments and drugs (4)
- Folic acid supplements: Can they slow cognitive decline?
- Alzheimer's nose spray: New Alzheimer's treatment?
- Vitamin B-12: Can it improve memory in Alzheimer's?
- see all in Treatments and drugs
Alternative medicine (4)
- Axona: Medical food to treat Alzheimer's
- Phosphatidylserine supplements: Can they improve memory?
- Vitamin B-12: Can it improve memory in Alzheimer's?
- see all in Alternative medicine
Mayo Clinic Health Manager
Get free personalized health guidance for you and your family.
Get StartedQuestion
Axona: Medical food to treat Alzheimer's
I've heard about a new Alzheimer's supplement called Axona. What does it do and can it really treat Alzheimer's?
Answer
from Glenn Smith, Ph.D.
Axona is a prescription supplement that claims to target the nutritional needs of people with Alzheimer's disease. Alzheimer's is thought to hinder the brain's ability to break down glucose. According to Axona's marketing materials, the supplement provides an alternative source of glucose that the brain can use for energy.
It's not clear what benefits, if any, Axona provides. A small study, funded by the manufacturers of the product, found that memory and cognition improved for people with mild to moderate Alzheimer's disease. However, more studies are needed to determine its safety and effectiveness.
Axona is marketed as a medical food. Medical foods are dietary supplements that help manage a disease or condition that causes nutritional deficiencies. The Alzheimer's Association, however, disputes the notion that Alzheimer's disease causes nutritional deficiencies and requires a medical food. Medical foods are given only under the supervision of a doctor. The Food and Drug Administration (FDA) doesn't approve medical foods, nor does it test medical foods for safety or effectiveness.
Until more is known, the Alzheimer's Association doesn't recommend the use of medical foods, including Axona, for the treatment of Alzheimer's disease.
Next questionPhosphatidylserine supplements: Can they improve memory?
- Is it really approved? Food and Drug Administration. http://www.fda.gov/consumer/updates/approvals093008.pdf. Accessed April 22, 2009.
- Medical food. Alzheimer's Association. http://www.alz.org/national/documents/statements_medicalfoods.pdf. Accessed April 22, 2009.
- Koenigsberg RA, et al. Neuroimaging. In: Goetz CG. Textbook of Clinical Neurology. 3rd ed. Philadelphia, Pa.: Elsevier Saunders; 2007. http://www.mdconsult.com/das/book/body/133328298-9/0/1488/208.html?tocnode=53801599&fromURL=208.html. Accessed April 23, 2009.
- Frequently asked questions. Accera, Inc. http://about-axona.com/faq.html. Accessed April 23, 2009.